-
In this paper, Dorian et al attempt to validate a relatively simple symptom scoring system for use in patients with atrial fibrillation (AF). The proposed Canadian Cardiovascular Society Severity in Atrial Fibrillation (CCS-SAF) scale is based upon symptoms attributable to AF, the association between symptoms and documentation of AF or AF therapies, and the functional consequences of these symptoms on the patient's daily life.
-
The recent literature is filled with trials of type II diabetes (DM) treatment and cardiovascular (CV) disease, with conflicting conclusions. While intuitively reasonable, not all trials of intensive glucose management in diabetes have been found to reduce CV events nor decrease CV mortality.
-
The role of intensive antiplatelet therapy for prevention of vascular events in patients with atrial fibrillation remains controversial.
-
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
-
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
-
-
Although it is well known that incessant atrial tachyarrhythmias can cause left ventricular (LV) dysfunction, little is known about focal atrial tachycardia and LV dysfunction.
-
Six years ago, Wild and Law, two British physicians, proposed that a single pill with multiple active components could profoundly reduce cardiac risk (CV).
-
The differential diagnosis of acute chest pain includes three entities that can be lethal if missed: myocardial infarction (MI), pulmonary embolus, and aortic dissection.
-
This report from Garza et al describes improved outcomes in out-of-hospital cardiac arrest victims after a cardiopulmonary resuscitation (CPR) protocol change by the emergency medical services (EMS) system in Kansas City, MO.